论文部分内容阅读
人类对于阿米巴病的认识,是自1785年L(?)sch 首先从粪便中发现阿米巴滋养体开始的,至今已有100多年的历史。据 WHO 报告,在我国,墨西哥、南美、非洲和东南亚各国都有此病的存在和流行.现在,它仍是一种世界性流行的寄生虫病.目前全世界约有4亿8千万人感染溶组织阿米巴,每年死于本病的人数约4~11万,在寄生虫病的死亡原因中,仅次于疟疾和血吸虫病,而居第三位。因此,本病近年来在各国重新引起人们的关注,并进行了多方面的研究,取得不少成果。现就本病的临床及治疗的某些方面作一介绍。
Human understanding of amebiasis began in 1785 when L?? Sch first discovered amebic trophozoites in the stool, and has been more than 100 years old. According to the WHO report, the presence and prevalence of the disease in our country, Mexico, South America, Africa and other Southeast Asian countries is still a worldwide epidemic of parasitic diseases, with about 480 million people worldwide Infection with Entamoeba histolytica, the number of deaths from the disease each year about 4 to 110 000, the cause of death in parasitic diseases, second only to malaria and schistosomiasis, and ranks third. Therefore, in recent years, the disease has aroused people’s attention in various countries and carried out many aspects of research and achieved a lot of results. Now on the clinical aspects of the disease and treatment for an introduction.